Loading data for LMAT — first visit, this takes a few seconds.

Alerta

LeMaitre Vascular Inc. (LMAT)

NasdaqGM: LMAT · Precio en tiempo real · USD

81.52

-0.99 (-1.20%)

Al cierre: Aug 19, 2026, 8:00 PM

82.50

-1.63%

Fuera de horario: 4:35 PM

-1.20% (1D)

No hay datos disponibles

Precio de compra	88.97
Capitalización de mercado	1.92B
Ingresos (TTM)	262.43M
Beneficio neto (TTM)	65.67M
Beta	0.52
EPS (TTM)	2.86
Ratio PER (TTM)	29.33
Adelante PE	26.38
P/B (TTM)	4.56
P/S (TTM)	7.31
Earnings Date	Nov 5, 2026

Precio de venta	109.9
Volumen	458,865
Volumen medio (20D)	367,601
Abierto	83.07
Anterior Cerrar	82.51
Rango del día	81.31 - 84.35
Rango de 52 semanas	78.65 - 118.01
analista	n/a
Precio objetivo	n/a
Dividendos	$1 (1.23%)
Fecha ex dividendo	20 ago 2026

Acerca de LMAT

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi i...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Oct 19, 2006

Empleados 646

Bolsa de Valores NasdaqGM

Símbolo bursátil LMAT

Sitio web https://www.lemaitre.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de LeMaitre Vascular fueron 249.6M, un aumento de 13.53% en comparación con 219.86M del año anterior. Las ganancias fueron 57.73M, un aumento de 31.1%.

Estados financieros

Sorpresa de resultados

LeMaitre Vascular ha publicado sus resultados trimestrales en Aug 4, 2026:

Ingresos de $70.38M falla las estimaciones por $0, con 9.57% Crecimiento interanual.

EPS de 0.74 falla las estimaciones por -0.07, con 23.33% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que LeMaitre Vascular Inc. publique sus resultados el Nov 5, 2026, durante el horario de mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

4 días hace · StockStory

Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks

Let’s dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - specialty earnings season.

6 días hace · Zacks

GEHC or LMAT: Which Is the Better Value Stock Right Now?

GEHC vs. LMAT: Which Stock Is the Better Value Option?

6 días hace · StockStory

The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call

LeMaitre’s second quarter was marked by strong organic revenue gains, led by robust growth in its Artegraft line and continued expansion across Europe and Asia. However, the quarter fell short of Wall...

1 semana hace · Motley Fool

LeMaitre Vascular (LMAT) Q2 2026 Earnings Call Transcript

Artegraft sales surged 34% as gross margins expanded to 72.1%.

1 semana hace · Simply Wall St.

31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update

What the latest earnings and guidance mean for LeMaitre Vascular stock LeMaitre Vascular (LMAT) has attracted fresh attention after reporting second quarter 2026 results that included higher sales and...

Página 1 de 2

LeMaitre Vascular Inc. (LMAT)